Allecra Therapeutics, a clinical stage biopharmaceutical company

Allecra was established in 2013 and is focused on the development of novel treatments to combat multi drug-resistant bacterial infections.

Allecra’s Mission

Allecra’s mission is to contribute towards the global effort to combat antibiotic resistance. Allecra aims to make its contribution by developing new treatments which overcome emerging resistance mechanisms, thereby saving lives of patients whose infections may otherwise be inadequately treated.

Allecra Therapeutics